Literature DB >> 14747548

Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Mahfuz Khan1, Lingling Jin, Ming Bo Huang, Lesa Miles, Vincent C Bond, Michael D Powell.   

Abstract

The viral protein Nef and the cellular factor cyclophilin A are both required for full infectivity of human immunodeficiency virus type 1 (HIV-1) virions. In contrast, HIV-2 and simian immunodeficiency virus (SIV) do not incorporate cyclophilin A into virions or need it for full infectivity. Since Nef and cyclophilin A appear to act in similar ways on postentry events, we determined whether chimeric HIV-1 virions that contained either HIV-2 or SIV Nef would have a direct effect on cyclophilin A dependence. Our results show that chimeric HIV-1 virions containing either HIV-2 or SIV Nef are resistant to treatment by cyclosporine and enhance the infectivity of virions with mutations in the cyclophilin A binding loop of Gag. Amino acids at the C terminus of HIV-2 and SIV are necessary for inducing cyclosporine resistance. However, transferring these amino acids to the C terminus of HIV-1 Nef is insufficient to induce cyclosporine resistance in HIV-1. These results suggest that HIV-2 and SIV Nef are able to compensate for the need for cyclophilin A for full infectivity and that amino acids present at the C termini of these proteins are important for this function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747548      PMCID: PMC369439          DOI: 10.1128/jvi.78.4.1843-1850.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

Authors:  M Y Chowers; C A Spina; T J Kwoh; N J Fitch; D D Richman; J C Guatelli
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

2.  Functional association of cyclophilin A with HIV-1 virions.

Authors:  M Thali; A Bukovsky; E Kondo; B Rosenwirth; C T Walsh; J Sodroski; H G Göttlinger
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

3.  The HIV-1 nef gene acts as a positive viral infectivity factor.

Authors:  M D Miller; M B Feinberg; W C Greene
Journal:  Trends Microbiol       Date:  1994-08       Impact factor: 17.079

4.  Association of Nef with the human immunodeficiency virus type 1 core.

Authors:  A Kotov; J Zhou; P Flicker; C Aiken
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Specific incorporation of cyclophilin A into HIV-1 virions.

Authors:  E K Franke; H E Yuan; J Luban
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

6.  Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.

Authors:  B D Jamieson; G M Aldrovandi; V Planelles; J B Jowett; L Gao; L M Bloch; I S Chen; J A Zack
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Spatial visualization of the maturing HIV-1 core and its linkage to the envelope.

Authors:  S Höglund; L G Ofverstedt; A Nilsson; P Lundquist; H Gelderblom; M Ozel; U Skoglund
Journal:  AIDS Res Hum Retroviruses       Date:  1992-01       Impact factor: 2.205

8.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.

Authors:  J Luban; K L Bossolt; E K Franke; G V Kalpana; S P Goff
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

9.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

10.  The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

Authors:  C A Spina; T J Kwoh; M Y Chowers; J C Guatelli; D D Richman
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  5 in total

1.  Structure of cyclophilin from Leishmania donovani at 1.97 A resolution.

Authors:  V Venugopal; Banibrata Sen; Alok K Datta; Rahul Banerjee
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-01-17

2.  HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.

Authors:  Tamika D Campbell; Mahfuz Khan; Ming-Bo Huang; Vincent Craig Bond; Michael D Powell
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

3.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Authors:  A D Raymond; T C Campbell-Sims; M Khan; M Lang; M B Huang; V C Bond; M D Powell
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

4.  Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant.

Authors:  Mahfuz Khan; Lingling Jin; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

Authors:  Elena Sokolskaja; David M Sayah; Jeremy Luban
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.